I am a board-certified clinical hematopathologist and an assistant professor in the Division of Hematopathology at Weill Cornell Medical College/NewYork-Presbyterian Hospital. I obtained my clinical and translational research fellowship training in hematopathology at the Brigham and Women's Hospital/Dana-Farber Cancer Institute.
Alongside my clinical activities in hematopathology, my research efforts have focused on the study of NPM1-mutated myeloid neoplasms (Patel et al. Blood 2018; Patel et al. Blood Adv 2019; Patel et al. Am J Hematol 2019; Patel et al. Mod Pathol 2020) and the interrogation of checkpoint protein targets in the classic Hodgkin lymphoma tumor microenvironment (Patel et al. Blood 2019). I am a past recipient of the David Y. Mason (European Association for Haematopathology) and Benjamin Castleman (United States and Canadian Academy of Pathology) Awards for some of my work in these areas.
My research approach broadly centers on the application of multi-omics techniques (e.g. DNA-based NGS, scRNA-seq, CyTOF, multiparametric in situ imaging) to fresh and archival patient materials in order to identify prognostic and predictive biomarkers in hematolymphoid neoplasia.
NPM1-mutated myeloid neoplasms
Acute lymphoblastic leukemias
Acute myeloid leukemia
Plasma cell neoplasms
classic Hodgkin lymphoma
I have extensive teaching experience, in the form of both large auditorium-based lectureship and small group/one-on-one based didactic sessions. I am currently actively involved in the education of medical students, residents, and fellows rotating in the Division of Hematopathology at Weill Cornell, and am also a member of the Residency Clinical Competency Committee (RCCC) within the Department of Pathology.